ArticleFrontiers in medicine2022

Effectiveness and safety of morinidazole in the treatment of pelvic inflammatory disease: A multicenter, prospective, open-label phase IV trial.

Ting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.